{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:57:00Z","timestamp":1762102620630,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10072-021-05180-8","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T01:05:21Z","timestamp":1616720721000},"page":"5087-5092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown"],"prefix":"10.1007","volume":"42","author":[{"given":"Alicia","family":"Gonzalez-Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Planchuelo-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel L","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3132-1064","authenticated-orcid":false,"given":"David","family":"Garc\u00eda-Azor\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Santos-Lasaosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Pilar","family":"Navarro-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Odriozola-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Irurtia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Quintas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"de Luis-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Beatriz","family":"Gago-Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"issue":"6","key":"5180_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/head.13830","volume":"60","author":"A Ali","year":"2020","unstructured":"Ali A (2020) Delay in onabotulinumtoxinA treatment during the COVID-19 pandemic\u2014perspectives from a virus hotspot. Headache. 60(6):1183\u20131186","journal-title":"Headache."},{"issue":"6","key":"5180_CR2","first-page":"372","volume":"35","author":"A L\u00f3pez-Bravo","year":"2020","unstructured":"L\u00f3pez-Bravo A, Garc\u00eda-Azor\u00edn D, Belv\u00eds R, Gonz\u00e1lez-Oria C, Latorre G, Santos-Lasaosa S et al (2020) Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives. Neurol (Engl Ed) 35(6):372\u2013380","journal-title":"Neurol (Engl Ed)"},{"issue":"5","key":"5180_CR3","first-page":"291","volume":"35","author":"S Santos-Lasaosa","year":"2020","unstructured":"Santos-Lasaosa S, Porta-Etessam J (2020) OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection. Neurol (Engl Ed) 35(5):291\u2013294","journal-title":"Neurol (Engl Ed)"},{"issue":"5","key":"5180_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/head.13810","volume":"60","author":"CL Szperka","year":"2020","unstructured":"Szperka CL, Ailani J, Barmherzig R, Klein BC, Minen MT, Halker Singh RB et al (2020) Migraine care in the era of COVID-19: clinical pearls and plea to insurers. Headache. 60(5):833\u2013842","journal-title":"Headache."},{"issue":"5","key":"5180_CR5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/head.13803","volume":"60","author":"M Silvestro","year":"2020","unstructured":"Silvestro M, Tessitore A, Tedeschi G, Russo A (2020) Migraine in the time of COVID-19. Headache. 60(5):988\u2013989","journal-title":"Headache."},{"issue":"1","key":"5180_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38(1):1\u2013211","journal-title":"Cephalalgia."},{"issue":"3","key":"5180_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0333102411434812","volume":"32","author":"E Loder","year":"2012","unstructured":"Loder E, Burch R (2012) Measuring pain intensity in headache trials: which scale to use? Cephalalgia. 32(3):179\u2013182","journal-title":"Cephalalgia."},{"issue":"3","key":"5180_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","volume":"41","author":"MJ Horowitz","year":"1979","unstructured":"Horowitz MJ, Wilner N, Alvarez W (1979) Impact of Event Scale: a measure of subjective stress. Psychosom Med 41(3):209\u2013218","journal-title":"Psychosom Med"},{"issue":"7","key":"5180_CR9","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/head.13880","volume":"60","author":"J Porta-Etessam","year":"2020","unstructured":"Porta-Etessam J, Gonzalez-Garcia N, Matias-Guiu JA, Montero-Escribano P, Mat\u00edas-Guiu J (2020) Should we adapt the prescription criteria for specific treatments for migraine due to the COVID-19 pandemic? Headache. 60(7):1448\u20131449","journal-title":"Headache."},{"issue":"9","key":"5180_CR10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00702-020-02235-6","volume":"127","author":"D Dressler","year":"2020","unstructured":"Dressler D, Adib SF (2020) Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort. J Neural Transm 127(9):1271\u20131274","journal-title":"J Neural Transm"},{"issue":"2","key":"5180_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10072-020-04940-2","volume":"42","author":"R Erro","year":"2021","unstructured":"Erro R, Scannapieco S, Russo M, Picillo M, Barone P (2021) Impact of COVID-19 on neurological patients attending a botulinum toxin service. Neurol Sci 42(2):433\u2013435","journal-title":"Neurol Sci"},{"issue":"1","key":"5180_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/head.13693","volume":"60","author":"A Gonzalez-Martinez","year":"2020","unstructured":"Gonzalez-Martinez A, Rodr\u00edguez V\u00e1zquez E, de la Red Gallego H, Garc\u00eda-Azor\u00edn D, Gallego de La Sacristana M, Guerrero Peral \u00c1L et al (2020) Association between personality traits and onabotulinumtoxinA response in patients with chronic migraine. Headache. 60(1):153\u2013161","journal-title":"Headache."},{"key":"5180_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/IJGM.S70456","volume":"8","author":"GP Boudreau","year":"2015","unstructured":"Boudreau GP, Grosberg BM, McAllister PJ, Lipton RB, Buse DC (2015) Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: an open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety. Int J Gen Med 8:79\u201386","journal-title":"Int J Gen Med"},{"issue":"12","key":"5180_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11916-018-0734-0","volume":"22","author":"MJ Marmura","year":"2018","unstructured":"Marmura MJ (2018) Triggers, protectors, and predictors in episodic migraine. Curr Pain Headache Rep 22(12):81","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"5180_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10072-020-04890-9","volume":"42","author":"M Consonni","year":"2021","unstructured":"Consonni M, Telesca A, Grazzi L, Cazzato D, Lauria G (2021) Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine. Neurol Sci 42(2):389\u2013397","journal-title":"Neurol Sci"},{"issue":"7","key":"5180_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jnnp-2015-312233","volume":"87","author":"MT Minen","year":"2016","unstructured":"Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R et al (2016) Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 87(7):741\u2013749","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 3","key":"5180_CR17","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1111\/j.1526-4610.2006.00559.x","volume":"46","author":"SM Baskin","year":"2006","unstructured":"Baskin SM, Lipchik GL, Smitherman TA (2006) Mood and anxiety disorders in chronic headache. Headache. 46(Suppl 3):S76\u2013S87","journal-title":"Headache."},{"key":"5180_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jad.2020.09.018","volume":"277","author":"\u00c1 Planchuelo-G\u00f3mez","year":"2020","unstructured":"Planchuelo-G\u00f3mez \u00c1, Odriozola-Gonz\u00e1lez P, Irurtia MJ, de Luis-Garc\u00eda R (2020) Longitudinal evaluation of the psychological impact of the COVID-19 crisis in Spain. J Affect Disord 277:842\u2013849","journal-title":"J Affect Disord"},{"issue":"12","key":"5180_CR19","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s10072-020-04767-x","volume":"41","author":"C Altamura","year":"2020","unstructured":"Altamura C, Cevoli S, Aurilia C, Egeo G, Fofi L, Torelli P et al (2020) Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study. Neurol Sci 41(12):3385\u20133389","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05180-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05180-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05180-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:07:30Z","timestamp":1638565650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05180-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5180"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05180-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"6 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Review Board of Valladolid East health area (PI 20-1832), based in the Hospital Cl\u00ednico Universitario de Valladolid (Valladolid, Spain).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}